Webinar | June 9, 2023

The Price Is Right: Approvals & Market Access In 2023

Source: Precision ADVANCE

Payers and purchasers are confronted with intricate deliberations concerning drug pricing, duration of effect, and reimbursement mechanisms, posing obstacles to accessibility.

In a session taking place on Cell & Gene Day 2023, moderator Phil Cyr, SVP of Precision Value & Health, joined life science experts as they shared their insights on how stakeholders across the treatment development continuum can collaborate to develop evidence and streamline these processes to enhance access.

Panelists featured in this webinar include:

  • Christopher Kurtz, CMO, Kate Therapeutics
  • Francesca Cook, VP Market Access, RegenXBio
  • Oswald Bentinck, VP Global Head of Value & Access, Rocket Pharma
  • Francis Pang, SVP Global Market Access, Orchard Therapeutics
access the Webinar!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene

Please tell us more about you so that we can customize our newsletters to your specific interests:

Precision ADVANCE